Name
|
Amount
and
Nature
of
Beneficial
Ownership
(1)
|
Percentage
of
Common
Stock
Outstanding
(2)
|
Percentage
of Shares of
Common
Stock
Outstanding
and
Operating
Partnership Interests (3)
|
||||||
George M.
Marcus(4)(5)
|
1,754,611
|
|
7.2%
|
6.9%
|
|||||
William A.
Millichap(4)(6)
|
588,891
|
|
2.5%
|
2.3%
|
|||||
Keith R.
Guericke(4)(7)
|
161,567
|
|
*
|
|
*
|
|
|||
Michael J.
Schall(4)(8)
|
98,674
|
|
*
|
|
*
|
|
|||
Michael
T. Dance(4)(9)
|
6,500
|
|
*
|
|
*
|
|
|||
John
D. Eudy(4)(10)
|
31,511
|
|
*
|
|
*
|
|
|||
Craig
K. Zimmerman(4)(11)
|
50,033
|
|
*
|
|
*
|
|
|||
David W.
Brady(4)(12)
|
2,500
|
|
*
|
|
*
|
|
|||
Robert E.
Larson(4)(13)
|
25,492
|
|
*
|
|
*
|
|
|||
Gary P.
Martin(4)(14)
|
22,500
|
|
*
|
|
*
|
|
|||
Issie N.
Rabinovitch(4)(15)
|
25,000
|
|
*
|
|
*
|
|
|||
Thomas E.
Randlett(4)(16)
|
32,295
|
|
*
|
|
*
|
|
|||
Willard H.
Smith, Jr.(4)(17)
|
25,000
|
|
*
|
|
*
|
|
|||
All
directors and executive officers as a group
(13 persons)(18)
|
2,352,140
|
|
9.5%
|
9.2%
|
|||||
Morgan
Stanley (19)
|
2,307,446
|
|
10.1%
|
9.1%
|
|||||
Deutsche
Bank AG (20)
|
1,784,000
|
|
7.8%
|
7.1%
|
|||||
Stichting
Pensioenfonds ABP (21)
|
1,439,900
|
|
6.3%
|
5.7%
|
|||||
Barclays
Global Investors Japan Trust and Banking Company Limited
(22)
|
1,265,498
|
5.5%
|
5.0%
|
Adelante
Capital Management LLC (23)
|
1,183,547
|
|
5.2%
|
4.7%
|
AMVESCAP,
PLC (24)
|
1,156,086
|
|
5.1%
|
4.6%
|
The
Vanguard Group, Inc. (25)
|
1,147,684
|
|
5.0%
|
4.5%
|
(1)
|
Mr. Marcus,
certain officers and directors of the Company and certain other entities
and investors own limited partnership interests in Essex Portfolio,
L.P.,
a California limited partnership (the “Operating Partnership”), which
presently aggregate to approximately a 9.7% limited partnership interest.
The Company presently has approximately 90.3% general partnership
interest
in the Operating Partnership. The limited partners of the Operating
Partnership share with the Company, as general partner, in the net
income
or loss and any distributions of the Operating Partnership. Pursuant
to
the partnership agreement of the Operating Partnership, limited
partnership interests can be exchanged into shares of the Company’s Common
Stock.
|
(2)
|
With
respect to shares of Common Stock, assumes exchange of the limited
partnership interests in the Operating Partnership held by such person,
if
any, into shares of the Company’s Common Stock. The total number of shares
outstanding used in calculating this percentage assumes that none
of the
limited partnership interests or vested options held by other persons
are
exchanged or converted into shares of the Company’s Common Stock and is
based on 22,873,421 shares of the Company’s Common Stock outstanding as of
the Record Date.
|
(3)
|
Assumes
exchange of all outstanding limited partnership interests (including
non-forfeitable Series Z and Series Z-1 Incentive Units) in the
Operating Partnership for shares of the Company’s Common Stock, which
would result in an additional 2,464,086 outstanding shares of the
Company’s Common Stock. Assumes that none of the interests in partnerships
(such as Downreits), other than the Operating Partnership, held by
other
persons are exchanged into shares of Common Stock, and that none
of the
vested stock options held by other persons are converted into shares
of
the Company’s Common Stock.
|
(4)
|
The
business address of such person is 925 East Meadow Drive, Palo Alto,
California 94303.
|
(5)
|
Includes
1,140,482 shares of Common Stock that may be issued upon the exchange
of
all of Mr. Marcus’ limited partnership interests in the Operating
Partnership and in certain other partnerships and 301,494 shares
and
15,941 shares of Common Stock that may be issued upon the exchange of
all the limited partnership interests in the Operating Partnership
held by
The Marcus & Millichap Company (“M&M”) and Essex Portfolio
Management Company (“EPMC”), respectively. Also includes 155,000 shares of
Common Stock held by M&M, 23,594 shares of Common Stock held in The
Marcus & Millichap Company 401(k) Plan (the “M&M 401(k) Plan”),
35,000 shares of Common Stock subject to options that are exercisable
within 60 days of the Record Date and 4,000 shares of Common Stock
held by Mr. Marcus’ children. Mr. Marcus is a principal
stockholder of each of M&M and EPMC and may be deemed to own
beneficially, and to share the voting and dispositive power of, 472,435
shares of Common Stock (including shares issuable upon exchange of
limited
partnership interests). Mr. Marcus disclaims beneficial ownership of
(i) all shares, options and limited partnership interests held by
M&M, and (ii) 6,376 shares of the 15,941 shares of Common Stock
that may be issued upon conversion of limited partnership interests
held
by EPMC.
|
(6)
|
Includes
73,099 shares of Common Stock that may be issued upon the exchange
of all
of Mr. Millichap’s limited partnership interests in the Operating
Partnership and 301,494 shares and 15,941 shares of Common Stock
that may
be issued upon the exchange of all of the limited partnership interests
in
the Operating Partnership held by M&M and EPMC, respectively. Also
includes 20,000 shares of Common Stock subject to options that are
exercisable within 60 days of the Record Date, 155,000 shares of
Common Stock held by M&M, and 15,957 shares of Common Stock held in
the M&M 401(k) Plan. Mr. Millichap is Chairman of Marcus &
Millichap Real Estate Investment Brokerage Company (an affiliate
of
M&M) and a principal stockholder in EPMC and may be deemed to own
beneficially, and to share the voting and dispositive power of, 472,435
shares of Common Stock (including shares issuable upon conversion
of
limited partnership interests). Mr. Millichap disclaims beneficial
ownership of (i) all shares, options and limited partnership
interests held by M&M and (ii) 9,565 shares of the 15,941 shares
of Common Stock that may be issued upon conversion of limited partnership
interests held by EPMC.
|
(7)
|
Includes
82,564 shares of Common Stock that may be issued upon the exchange
of all
of Mr. Guericke’s limited partnership interests in the Operating
Partnership. Also includes 7,427 shares of Common Stock subject to
options
that are exercisable within 60 days of the Record Date, 5,279 shares
of Common Stock held in the Essex Property Trust, Inc. 401(k) Plan
(the
“Essex 401(k) Plan”), and 22,658 shares that may be issued in exchange for
non-forfeitable Series Z and Series Z-1 Incentive Units.
Excludes 27,817 shares of Common Stock issuable upon satisfying certain
requirements of the Series Z and Series Z-1 Incentive
Units.
|
(8)
|
Includes
35,354 shares of Common Stock that may be issued upon the exchange
of all
of Mr. Schall’s limited partnership interests in the Operating
Partnership. Also includes 3,853 shares of Common Stock held in the
Essex
401(k) Plan, and 19,837 shares that may be issued in exchange for
non-forfeitable Series Z and Series Z-1 Incentive Units. Further
includes 860 shares of Common Stock held by Mr. Schall’s three
children. Excludes 24,888 shares of Common Stock issuable upon satisfying
certain requirements of the Series Z and Series Z-1 Incentive
Units.
|
(9)
|
Includes
2,000 shares of Common Stock subject to options that are exercisable
within 60 days of the Record Date and 4,500 shares that may be issued
in exchange for non-forfeitable Series Z-1 Incentive Units. Excludes
10,500 shares of Common Stock issuable upon satisfying certain
requirements of the Series Z-1 Incentive
Units.
|
(10)
|
Includes
7,457 shares of Common Stock that may be issued upon the exchange
of all
of Mr. Eudy’s limited partnership interests in the Operating
Partnership. Also includes 1,495 shares of Common Stock held in the
Essex
401(k) Plan and 16,689 shares that may be issued in exchange for
non-forfeitable Series Z and Series Z-1 Incentive Units.
Excludes 21,012 shares of Common Stock issuable upon satisfying certain
requirements of the Series Z and Series Z-1 Incentive
Units.
|
(11)
|
Includes
25,425 shares of Common Stock that may be issued upon the exchange
of all
of Mr. Zimmerman’s limited partnership interests in the Operating
Partnership and certain other partnerships. Also includes 16,689
shares
that may be issued in exchange for non-forfeitable Series Z and
Series Z-1 Incentive Units. Excludes 21,012 shares of Common Stock
issuable upon satisfying certain requirements of the Series Z and
Series Z-1 Incentive Units.
|
(12)
|
Includes
2,500 shares of Common Stock subject to options that are exercisable
within 60 days of the Record
Date.
|
(13)
|
Includes
15,000 shares of Common Stock subject to options that are exercisable
within 60 days of the Record
Date.
|
(14)
|
Includes
17,500 shares of Common Stock subject to options that are exercisable
within 60 days of the Record
Date.
|
(15)
|
Includes
12,500 shares of Common Stock subject to options that are exercisable
within 60 days of the Record
Date.
|
(16)
|
Includes
16,529 shares of Common Stock subject to options that are exercisable
within 60 days of the Record
Date.
|
(17)
|
Includes
20,000 shares of Common Stock subject to options that are exercisable
within 60 days of the Record Date. Mr. Smith is a director of
certain funds of Cohen & Steers and he disclaims beneficial ownership
of the shares of Common Stock of the Company held by Cohen & Steers
Capital Management.
|
(18)
|
Includes
1,681,816 shares of Common Stock that may be issued upon the exchange
of
all of the executive officers’ and directors’ limited partnership
interests in the Operating Partnership and certain other partnerships
and
148,456 shares of Common Stock subject to options that are exercisable
within 60 days of the Record Date. Also, includes 80,374 shares that
may be issued in exchange for non-forfeitable Series Z and
Series Z-1 Incentive Units. Excludes 105,228 shares of Common Stock
issuable upon satisfying the requirements of the Series Z and
Series Z-1 Incentive Units.
|
(19)
|
As
reported on Schedule 13G, filed January 24, 2006, Morgan Stanley
Investment Management, Inc. is a wholly owned subsidiary of Morgan
Stanley. Morgan Stanley has the shared power to vote and direct the
vote
of 737 shares and shared dispositive power over 737 shares, sole
power to
vote and direct the vote of 1,679,718 shares and sole dispositive
power
over 1,679,718 shares. Morgan Stanley Investment Management, Inc.
has the
sole power to vote and direct the vote of 1,518,814 shares and sole
dispositive power over 1,518,814 shares. Addresses: Morgan Stanley,
1585 Broadway, New York, New York 10036; Morgan Stanley Investment
Management, Inc., 1221 Avenue of the Americas, New York, New York
10020.
|
(20)
|
As
reported on Schedule 13G, filed January 24, 2006, RREEF America,
L.L.C., a
subsidiary of Deutsche Bank AG, has the sole power to vote and direct
the
vote of 1,784,000 shares and sole dispositive power over 1,784,000
shares.
The address for Deutsche Bank AG is Taunusanlage 12, D-60325, Frankfurt
am
Main, Federal Republic of Germany.
|
(21)
|
As
reported on Schedule 13G, filed February 14, 2006, Stichting
Pensioenfonds ABP has the sole power to vote or direct the vote of
1,439,900 shares and the sole dispositive power over 1,439,900 shares.
The
address for Stichting Pensioenfonds ABP is Oude Lindestraat 70, Post
bus
2889, 6401 DL Heerlen, The Kingdom of the
Netherlands.
|
(22)
|
As
reported on Schedule 13G, filed January 26, 2006, Barclays Global
Investors Japan Trust and Banking Company Limited (“Barclays”) has the
sole power to vote and direct the vote of 1,194,569 shares and sole
dispositive power over 1,265,498 shares. The address of Barclays
is Ebisu
Prime Square Tower, 8th Floor, 1-1-39 Hiroo Shibuya-ku, Tokyo 150-0012
Japan.
|
(23)
|
As
reported on Schedule 13G filed February 14, 2006, Adelante Capital
Management LLC is an investment advisor registered under Section
203 of
the Investment Advisors Act of 1940. Adelante Capital Management
LLC has
the sole dispositive power over 1,183,547 shares. The address for
Adelante
Capital Management LLC is 555 12th Street, Suite 2100, Oakland,
CA 94607.
|
(24)
|
As
reported on Schedule 13G filed February 13, 2006, AMVESCAP PLC is the
U.K. parent company of various INVESCO investment adviser subsidiaries.
Such INVESCO subsidiaries have the sole power to vote and direct
the vote
of 1,156,086 shares and sole dispositive power over 1,156,086 shares.
The
address for AMVESCAP PLC is 30 Finsbury Square, London EC2A 1AG,
England.
|
(25)
|
As
reported on Schedule 13G, filed February 13, 2006, The Vanguard Group,
Inc., and its wholly owned subsidiary, Vanguard Fiduciary Trust Company,
have the sole power to vote and direct the vote of 8,876 shares and
sole
dispositive power over 1,147,684 shares. The address for The Vanguard
Group, Inc. is 100 Vanguard Boulevard, Malbern, PA
19355.
|
Name
and Position
|
Age
|
First
Elected
|
Term
Expires
|
||||
George M.
Marcus
Chairman
of the
Board
|
64
|
|
1994
|
|
2006
|
|
|
William A.
Millichap
Director
|
62
|
|
1994
|
|
2006
|
|
|
Keith R.
Guericke
Vice
Chairman of
the Board, Chief Executive Officer and President
|
57
|
|
1994
|
|
2007
|
|
|
Michael J.
Schall
Director,
Senior
Executive Vice President and Chief Operating Officer
|
48
|
|
1994
|
|
2008
|
|
|
Michael T.
Dance
Executive
Vice
President and Chief Financial Officer
|
49
|
|
—
|
|
—
|
|
|
John
D. Eudy
Executive
Vice President-Development
|
51
|
|
—
|
|
—
|
|
|
Craig
K. Zimmerman
Executive
Vice
President-Acquisitions
|
55
|
|
—
|
|
—
|
|
|
David W.
Brady
Director
|
65
|
|
1994
|
|
2008
|
|
|
Robert E.
Larson
Director
|
67
|
|
1994
|
|
2008
|
|
|
Name
and Position
|
Age
|
First
Elected
|
Term
Expires
|
Gary P.
Martin
Director
|
58
|
|
1994
|
|
2006
|
|
|
Issie N.
Rabinovitch
Director
|
59
|
|
1994
|
|
2007
|
|
|
Thomas E.
Randlett
Director
|
63
|
|
1994
|
|
2007
|
|
|
Willard H.
Smith, Jr.
Director
|
69
|
|
1996
|
|
2008
|
|
|
Director
|
Executive
|
Audit
|
Compensation
|
Stock
Incentive Plan
|
Nominating/
Corporate
Governance
|
Pricing
|
David
W. Brady
|
X
|
|||||
Keith
R. Guericke
|
X
|
X
|
||||
Robert
E. Larson
|
X
|
X
|
X
|
|||
George
M. Marcus
|
Chair
|
X
|
||||
Gary
P. Martin
|
X
|
Chair
|
||||
William
A. Millichap
|
||||||
Issie
N. Rabinovitch
|
Chair
|
X
|
X
|
|||
Thomas
E. Randlett
|
X
|
Chair
|
Chair
|
|||
Michael
J. Schall
|
X
|
|||||
Willard
H. Smith, Jr.
|
Chair
|
· |
A
director is not independent if the director is, or has been within
the
last three years, an employee of the Company, or an immediate family
member is, or has been within the last three years, an executive
officer
of the Company.
|
· |
A
director is not independent if the director has received, or has
an
immediate family member that is an executive officer of the Company
and
who has received, during any twelve month period with the last three
years, more than $100,000 in direct compensation from the Company
(other
than director and committee fees and compensation or other forms
of
deferred compensation for prior service, which compensation is not
contingent upon continued service).
|
· |
A
director is not independent if (i) the director or an immediate family
member is a current partner of a firm that is the Company’s internal or
external auditor; (ii) the director is a current employee of such
a firm,
(iii) the director has an immediate family member who is a current
employee of such a firm and who participates in the firm’s audit,
assurance or tax compliance (but not tax planning) practice; or (iv)
the
director or an immediate family member was within the last three
years
(but is no longer) a partner or employee of such a firm and personally
worked on the Company’s audit within that
time.
|
· |
A
director is not independent if the director or an immediate family
member
is, or has been within the last three years, employed as an executive
officer of any other company where any of the Company’s present executive
officers at the same time serves or served on that company’s compensation
committee.
|
· |
A
director is not independent if the director is a current employee,
or an
immediate family member is a current executive officer, of a company
that
has made payments to, or received payments from, the Company for
property
or services in an amount which, in any of the last three fiscal years,
exceeds the greater of $1 million, or 2% of such other company’s
consolidated gross revenues.
|
· |
A
director is not independent if the director serves an executive officer
of
any tax exempt organization to which the Company has made, within
the
preceding three years, contributions in any single fiscal year that
exceeded the greater of $1 million, or 2% of such tax exempt
organization’s consolidated gross revenues.
|
● |
An
annual grant of options to purchase 2,500 shares of the Company’s Common
Stock at the closing market price of the Common Stock on the date
of
grant. This annual grant occurs as of the annual shareholder’s meeting
date. In 2005, pursuant to this arrangement, each director, who was
not an
executive officer, received a grant of an option to purchase 2,500
shares
of Common Stock at an exercise price of
$79.25.
|
● |
An
annual cash retainer, paid quarterly, in the amount of $22,000 per
year.
|
● |
A
board attendance fee of $1,000 per meeting
attended.
|
● |
A
committee attendance fee of $500 per meeting, except as to regularly
scheduled Audit Committee meetings, for which a $1,000 attendance
fee is
paid. With the exception of meetings of the Audit Committee, no meeting
attendance fees shall apply when both Board of Directors and committee
meetings occur on the same day.
|
● |
The
Chairman of the Audit Committee, Mr. Randlett, receives $10,000 per
year, payable quarterly, in addition to the other compensation indicated
above.
|
Director
|
Total
2005 Compensation
|
Annual
Cash Retainer
|
Board
Attendance
Fee
|
Committee
Attendance Fee
|
Committee
Chair Fee
|
Option
Awards(1)
|
David
W. Brady
|
$67,875
|
$22,000
|
$7,000
|
$6,500
|
-
|
$32,375
|
Robert
E. Larson
|
$67,875
|
$22,000
|
$7,000
|
$6,500
|
-
|
$32,375
|
George
M. Marcus
|
$69,875
|
$22,000
|
$8,000
|
$7,500
|
-
|
$32,375
|
Gary
P. Martin
|
$70,375
|
$22,000
|
$7,000
|
$9,000
|
-
|
$32,375
|
William
A. Millichap
|
$62,375
|
$22,000
|
$8,000
|
-
|
-
|
$32,375
|
Issie
N. Rabinovitch
|
$66,875
|
$22,000
|
$7,000
|
$5,500
|
-
|
$32,375
|
Thomas
E. Randlett
|
$86,375
|
$22,000
|
$7,000
|
$15,000
|
$10,000
|
$32,375
|
Willard
H. Smith, Jr.
|
$60,240
|
$22,000
|
$5,865
|
-
|
-
|
$32,375
|
(1)
|
The
value represents the spread between the exercise price of the stock
options, which is $79.25 per share, and $92.20, the closing price
per
share of the underlying shares of Common Stock, as reported on the
New
York Stock Exchange on December 30, 2005 (the last trading day of
fiscal
year 2005).
|
Annual
Compensation
|
Long
Term Compensation
|
||||||||||||
Awards
|
|||||||||||||
Name
and Position
|
Year
|
Salary($)
|
Bonus($)
|
Restricted
Stock
Awards($)(1)
|
Securities
Underlying
Stock
Options/
SARs(#)
|
||||||||
Keith R.
Guericke
Vice
Chairman of the Board,
Chief
Executive Officer and
President
|
2005
|
$
|
297,115
|
$
|
662,000(2)
|
$
|
963,520(3)
|
—
|
|||||
|
2004
|
$
|
278,000
|
$
|
600,000
|
$
|
717,033(4)
|
—
|
|||||
|
2003 |
|
$
|
300,000
|
|
—
|
—
|
—
|
|||||
|
|
|
|
|
|
||||||||
|
|||||||||||||
Michael J.
Schall
Director,
Senior Executive
Vice
President and
Chief
Operating Officer
|
2005
|
$
|
242,644
|
$
|
575,000(2)
|
$
|
867,316(3)
|
—
|
|
||||
|
2004 |
$
|
252,500
|
$
|
600,000
|
$
|
717,033(4)
|
—
|
|
||||
|
2003 |
|
$
|
275,000
|
|
—
|
—
|
—
|
|
||||
|
|
|
|
|
|
||||||||
|
|||||||||||||
Michael
T. Dance (5)
Executive
Vice President and
Chief
Financial Officer
|
2005
|
$
|
153,538
|
$
|
187,500
|
$
|
1,021,500(3)
|
10,000
|
|
||||
|
2004 |
|
|||||||||||
|
2003 |
|
|
|
|
|
|||||||
|
|
|
|
|
|
||||||||
John
D. Eudy
Executive
Vice President-
Development
|
2005
|
$
|
199,038
|
$
|
325,000
|
$
|
770,927(3)
|
—
|
|
||||
|
2004 |
$
|
100,000
|
$
|
525,000
|
$
|
551,548(4)
|
—
|
|
||||
|
2003 |
|
$
|
100,000
|
$
|
100,000
|
|
—
|
|
—
|
|
||
Robert
C. Talbott (6)
Senior
Vice President
|
2005
|
$
|
172,371
|
$
|
350,000
|
—
|
—
|
||||||
|
2004 |
$
|
100,000
|
$
|
335,000
|
$
|
330,970(4)
|
—
|
|||||
|
2003 |
$
|
100,000
|
$
|
60,000
|
—
|
—
|
||||||
|
|||||||||||||
Craig
K. Zimmerman
Executive
Vice President-
Acquisitions
|
2005
|
|
$
|
199,038
|
$
|
275,000
|
$
|
770,927(3)
|
—
|
|
|||
|
2004 |
$
|
100,000
|
$
|
650,000
|
$
|
551,548(4)
|
—
|
|
||||
|
2003 |
|
$
|
100,000
|
$
|
100,000
|
|
—
|
|
—
|
|
(1)
|
Represents
Series Z-1 Incentive Units of limited partnership (“Series Z-1
Incentive Units”) in Essex’s Operating Partnership, which, upon certain
triggering events, will automatically convert into common units of
limited
partnership interest in the Operating Partnership based on a conversion
ratio that may increase over time upon satisfaction of specific
conditions. Common units of the Operating Partnership are exchangeable
on
a one-for-one basis into shares of the Company’s Common Stock. The
conversion ratio of Series Z-1 Incentive Units into common units was
initially set at 20% and will increase by up to 10% on January 1 of
each year for each participating executive who remains employed by
the
Company if the Company has met a specified “funds from operations” per
share target for the prior years, or such other target as the Compensation
Committee deems appropriate, up to a maximum conversion ratio of
100%.
|
(2)
|
Also
reflects the Company’s foregiveness of loans in January 2006 which (i) for
Mr. Guericke totaled $150,000 in principal and approximately $112,000
in
accrued interest and (ii) for Mr. Schall totaled $100,000 in principal
and
approximately $75,000 in accrued
interest.
|
(3)
|
In
2005, Essex granted Messrs. Guericke, Schall, Eudy, Dance, and
Zimmerman, 10,456, 9,412, 8,366, 15,000 and 8,366 Series Z-1
Incentive Units, respectively.
|
(4)
|
In
2004, Essex granted Messrs. Guericke, Schall, Eudy, Talbott and
Zimmerman 10,607, 10,607, 8,159, 4,896, and 8,159 Series Z-1 Incentive
Units, respectively. The amounts in the above table for such 2004
Series
Z-1 Incentive Unit grants are based on valuing these units as of
the date
of their grant in 2004, using the same methodology as discussed above
for
the 2005 Series Z-1 Incentive Unit grants. See footnote three above.
Based
on the closing price of the Essex common stock on December 30, 2005
of
$92.20 (and less the $1.00 capital contribution), such values as
of
December 30, 2005 for the Series Z-1 Incentive Units granted to the
above
named persons in 2004 are as follows: Mr. Guericke, 10,607 units
($967,358), Mr. Schall, 10,607 units ($967,358), Mr. Eudy, 8,159
units
($744,101), Mr. Talbott, 4,896 units ($446,515), and Mr. Zimmerman,
8,159
units ($744,101).
|
(5)
|
Michael
T. Dance was hired as the Company’s Executive Vice President and Chief
Financial Officer on February 15,
2005.
|
(6)
|
Mr.
Talbott resigned from his position at the Company, effective January
2006.
|
|
|
||||||
Name
|
Number
of
Securities
Underlying
Options
Granted(#)
|
Percent
of
Total
Options
Granted
to
Employees
in
Fiscal
Year(1)
|
Exercise
Price
Per
Share($/Sh)(2)
|
Expiration
Date(3)
|
Potential
Realizable
Value
at Assumed
Annual
Rate of Stock
Price
Appreciation for
Option
Term(4)
|
||
5%
|
10%
|
||||||
Michael
T. Dance
|
10,000
|
5.3%
|
$72.70
|
2/22/2015
|
$457,206
|
|
$1,158,650
|
(1)
|
For
the fiscal year ended December 31, 2005, the Company granted options
to employees to purchase an aggregate of 188,800
shares.
|
(2)
|
The
exercise price per share of options granted represented the fair
market
value of the underlying shares of Common Stock at the date the options
were granted.
|
(3)
|
Options
may terminate before their expiration dates if the optionee's status
as an
employee or consultant is terminated or upon the optionee’s death or
disability.
|
(4)
|
Such
amounts have been calculated as the exercise price multiplied by
the
respective annual assumed growth rate (compounded), less the exercise
price of the underlying option, multiplied by the number of options
granted.
|
Name
|
Number
of
Shares
Acquired
Upon
Exercise
|
Value
Realized
Upon
Exercise(1)
|
Number
of Securities
Underlying
Unexercised
Options
At Fiscal Year-End (1)
|
Value
of Unexercised
In-the-Money
Options
at
Fiscal Year-End($)(2)
|
|||||||||||
Exercisable
|
Unexercisable
|
Exercisable
|
Unexercisable
|
||||||||||||
Keith R.
Guericke
|
20,000
|
|
$1,057,500
|
|
7,427
|
|
—
|
|
$430,394
|
|
—
|
|
|||
|
|
|
|
|
|
||||||||||
Michael
J. Schall
|
4,573
|
|
$236,652
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|||
|
|
|
|
|
|
||||||||||
Michael
T. Dance
|
—
|
|
—
|
|
—
|
|
10,000
|
|
—
|
|
$195,000
|
|
|||
|
|
|
|
|
|
||||||||||
John
D. Eudy
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|||
|
|
|
|
|
|
||||||||||
Robert
C. Talbott
|
2,869
|
|
$155,104
|
|
6,262
|
|
—
|
|
$377,360
|
|
—
|
|
|||
|
|
|
|
|
|
||||||||||
Craig
K. Zimmerman
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|||
(1)
|
The
value realized upon the exercise of stock options represents the
positive
spread between the exercise price of stock options and the fair market
value on the exercise date.
|
(2)
|
The
value of “in-the-money” stock options represents the positive spread
between the exercise price of options and $92.20, the closing price
per
share of the underlying shares of Common Stock, as reported on the
New
York Stock Exchange on December 30, 2005 (the last trading day of
fiscal year 2005).
|
Plan
Category
|
Number
of Securities
To
Be Issued Upon Exercise Of
Outstanding
Options,
Warrants
And Rights
|
Weighted
Average
Exercise
Price For
Outstanding
Options,
Warrants
And Rights
|
Securities
Remaining
Available
for Future
Issuance
Under Plans
|
|||||
Equity
compensation plans
approved
by security holders:
|
|
|
|
|||||
Option
Plans
|
530,375
|
|
$
|
43.77(1)
|
977,700
|
|
||
Equity
compensation plans not
approved
by security holders:
|
|
|
|
|||||
Series Z
Incentive Units(2)
|
200,000
|
|
N/A
|
|
0
|
|
||
Series Z-1
Incentive Units(2)
|
212,952
|
|
N/A
|
|
187,048
|
|
||
Total
|
943,327
|
|
—
|
|
1,164,748
|
|
(1)
|
This
weighted average price amount applies only to options granted under
the
Company’s 1994 and 2004 plans.
|
(2)
|
Series
Z and Series Z-1 Incentive Units are convertible, upon certain triggering
events, into common units of the Operating Partnership, which in
turn are
exchangeable on a one-for-one basis for shares of the Company’s Common
Stock. As of the Record Date, the conversion ratio for Series Z Incentive
Units was 55.5% and the conversion rate for Series Z-1 Incentive
Units
ranged from 20% to 40%, respectively. These conversion ratios may
increase
over time, up to 100%, upon satisfaction of specific conditions.
See
“Series Z and Series Z-1 Incentive Units”
below.
|
Compensation
Committee of
|
The
Board of Directors
|
Robert
E. Larson
|
George
M. Marcus
|
Issie
N. Rabinovitch
|
|
Period
Ending
|
|||||
Index
|
12/31/00
|
12/31/01
|
12/31/02
|
12/31/03
|
12/31/04
|
12/31/05
|
Essex
Property Trust, Inc.
|
100.00
|
95.55
|
104.30
|
138.86
|
189.35
|
216.68
|
S&P
500
|
100.00
|
88.11
|
68.64
|
88.33
|
97.94
|
102.74
|
NAREIT
All Equity REIT Index
|
100.00
|
113.93
|
118.29
|
162.21
|
213.43
|
239.39
|
Fiscal
2004
|
Fiscal
2005
|
||||||
Audit
Fees (1)
|
$
|
1,239,574
|
|
$
|
1,156,394
|
|
|
Audit-Related
Fees (2)
|
—
|
|
—
|
|
|||
Tax
Fees (3)
|
265,838
|
|
268,124
|
|
|||
All
Other Fees (4)
|
—
|
|
—
|
|
|||
Total
|
$
|
1,505,412
|
|
$
|
1,424,518
|
|
|
|
(1)
|
Audit
Fees consist of fees billed for professional services rendered
for the
audit of the Company’s consolidated annual financial statements and the
audit of internal controls and the related management assessment
of
internal controls, and review of the interim consolidated financial
statements included in quarterly reports and services that are
normally
provided by KPMG LLP in connection with statutory and regulatory
filings
or engagements.
|
(2)
|
Audit-Related
Fees consist of fees billed for assurance and related services
that are
reasonably related to the performance of the audit or review of
the
Company’s consolidated financial statements and are not reported under
“Audit Fees.” There were no Audit-Related Fees incurred in fiscal 2005 or
fiscal 2004.
|
(3)
|
Tax
Fees consist of fees billed for professional services rendered
for tax
compliance, tax advice and tax planning. These services include
assistance
regarding federal and state tax compliance and tax
planning.
|
(4)
|
All
Other Fees consist of fees for products and services other than
the
services reported above. There were no fees in this category incurred
in
fiscal 2005 or fiscal 2004.
|
1. |
Review
the policies and procedures adopted by the Company to fulfill its
responsibilities regarding the fair and accurate presentation of
financial
statements in accordance with generally accepted accounting principles
and
applicable rules and regulations of the SEC and the NYSE;
|
2. |
Review
analyses specifically prepared by management and/or the Company’s
independent auditor dealing with significant financial reporting
issues
and judgments made in connection with the preparation of the Company’s
financial statements, including analyses of the effects of alternative
generally accepted accounting principles (“GAAP”)
methods on the financial statements;
|
3. |
Review
major issues regarding accounting principles and financial statement
presentations, including any significant changes in the Company’s
selection or application of accounting principles, and major issues
as to
the adequacy of the Company’s internal controls and any special audit
steps adopted in light of material control deficiencies;
|
4. |
Discuss
policies with respect to risk assessment and risk management, and
discuss
the Company’s major financial risk exposures and the steps management has
taken to monitor and control such exposures;
|
5. |
Review
with the Company’s independent auditor, management and internal auditors
any information regarding “second” opinions sought by management from an
independent auditor with respect to the accounting treatment of a
particular event or transaction;
|
6. |
Review
and discuss with management and the Company’s independent auditor the
effect of regulatory and accounting initiatives, as well as off-balance
sheet arrangements and aggregate contractual obligations, on the
Company’s
financial statements;
|
7. |
Review
and discuss reports from the Company’s independent auditor regarding: (a)
all critical accounting policies and practices to be used by the
Company;
(b) all alternative treatments of financial information within GAAP
that
have been discussed with management, including ramifications of the
use of
such alternative disclosures and treatments and the treatment preferred
by
the independent auditor; and (c) other material written communications
between the independent auditor and management, such as any management
letter or schedule of unadjusted differences;
|
8. |
Review
and discuss with management the Company’s audited financial statements.
Review and discuss the Company’s annual audited financial statements and
quarterly financial statements with management and the Company’s
independent auditor, including the Company’s disclosures under
“Management’s Discussion and Analysis of Financial Condition and Results
of Operations”;
|
9. |
Discuss
the Company’s earnings press releases (including type and presentation of
information), as well as financial information and earnings guidance
provided to analysts and ratings agencies;
|
10. |
If
deemed appropriate, recommend to the Board that the Company’s audited
financial statements be included in its annual report on Form 10-K
for the
last fiscal year;
|
11. |
Prepare
and approve the report required by the rules of the SEC to be included
in
the Company’s annual proxy statement in accordance with the requirements
of Item 7(d)(3)(i) of Schedule 14A and Item 306 of Regulation S-K;
|
12. |
Meet
separately, periodically, with management, with the Company’s internal
auditors (or other personnel responsible for the internal audit function)
and with the Company’s independent auditor;
|
13. |
Be
directly responsible, in its capacity as a committee of the Board,
for the
appointment, compensation, retention and oversight of the work of
any
registered public accounting firm engaged (including resolution of
disagreements between management and the auditor regarding financial
reporting) for the purpose of preparing or issuing an audit report
or
performing other audit, review or attest services for the Company;
provided also that each such registered public accounting firm shall
report directly to the Committee;
|
14. |
Receive
and review a formal written statement and letter from the Company’s
independent auditor delineating all relationships between the independent
auditor and the Company, consistent with Independence Standards Board
Standard 1, as may be modified or supplemented;
|
15. |
Actively
engage in a dialogue with the Company’s independent auditor with respect
to any disclosed relationship or services that may impact the objectivity
and independence of the independent auditor;
|
16. |
Establish
policies and procedures for review and pre-approval by the Committee
of
all audit services and permissible non-audit services (including
the fees
and terms thereof) to be performed by the Company’s independent auditor,
with exceptions provided for de
minimis amounts
under certain circumstances as permitted by law; provided, however,
that:
(a) the Committee may delegate to one (1) or more Members the authority
to
grant such pre-approvals if the pre-approval decisions of any such
delegate Member(s) are presented to the Committee at its next-scheduled
meeting; and (b) all approvals of non-audit services to be performed
by
the independent auditor must be disclosed in the Company’s applicable
periodic reports;
|
17. |
Obtain
and review, at least annually, a report by the Company’s independent
auditor describing: (a) the independent auditor’s internal quality-control
procedures; (b) any material issues raised by the most recent internal
quality-control review, or peer review, of the independent auditor,
or by
any inquiry or investigation by governmental or professional authorities,
within the preceding five (5) years, respecting one or more audits
carried
out by the independent auditor, and any steps taken to deal with
any such
issues; and (c) all relationships between the independent auditor
and the
Company (to assess the auditor’s independence);
|
18. |
Discuss
with the Company’s independent auditor the matters required to be
discussed by Statement on Auditing Standards No. 61, as may be modified
or
supplemented, relating to the conduct of the audit;
|
19. |
Review
with the Company’s independent auditor any audit problems, difficulties or
disagreements with management that the independent auditor may have
encountered, as well as any management letter provided by the independent
auditor and the Company’s response to that letter, including a review of:
(a) any difficulties encountered in the course of the audit work,
including any restrictions on the scope of activities or access to
required information; (b) any changes required in the planned scope
of the
internal audit; and (c) the Company’s internal audit department’s
responsibilities, budget and staffing;
|
20. |
Review
and evaluate the qualifications, performance and independence of
the
Company’s independent auditor and its lead partner, and present the
Committee’s conclusions to the Board;
|
21. |
Oversee
the rotation of the lead (or coordinating) audit partner of the Company’s
independent auditor having primary responsibility for the audit and
the
audit partner responsible for reviewing the audit at least every
five (5)
years;
|
22. |
Review
the Company’s annual audited financial statements with management,
including a review of major issues regarding accounting and auditing
principles and practices, and evaluate the adequacy and effectiveness
of
internal controls that could significantly affect the Company’s financial
statements, as well as the adequacy and effectiveness of the Company’s
disclosure controls and procedures and management’s reports thereon;
|
23. |
Review
major changes to the Company’s auditing and accounting principles and
practices as suggested by the Company’s independent auditor, internal
auditors or management;
|
24. |
Review
the appointment of, and any replacement of, the Company’s senior internal
auditing executive;
|
25. |
Review
the significant reports to management prepared by the Company’s internal
auditing department and management’s responses;
|
26. |
Advise
the Board with respect to the Company’s policies and procedures regarding
compliance with applicable laws and regulations;
|
27. |
Establish
procedures for: (a) the receipt, retention and treatment of complaints
received by the Company regarding accounting, internal accounting
controls, or auditing matters; and (b) the confidential, anonymous
submission by employees of the Company of concerns regarding questionable
accounting or auditing matters;
|
28. |
Review
and address any concerns regarding potentially illegal actions raised
by
the Company’s independent auditor pursuant to Section 10A(b) of the Act,;
|
29. |
Review
and reassess the adequacy of the Charter annually;
|
30. |
Review
and assess the performance and effectiveness of the Committee at
least
annually;
|
31. |
Report
regularly to the Board with respect to the Committee’s activities and make
recommendations as appropriate. Report regularly to the Board, and
review
with the Board any issues that arise with respect to the quality
or
integrity of the Company’s financial statements, the Company’s compliance
with legal or regulatory requirements, the performance and independence
of
the Company’s independent auditor, or the performance of the Company’s
internal audit function;
|
32. |
Review
with the Company’s outside counsel and internal legal counsel any legal
matters that may have a material impact on the financial statements,
the
Company’s compliance policies and any material reports or inquiries
received from regulators or governmental agencies;
|
33. |
Provide
oversight and review of the Company’s asset management policies, including
an annual review of the Company’s investment policies and performance for
cash and short-term investments; and
|
34. |
Take
any other actions that the Committee deems necessary or proper to
fulfill
the purposes and intent of this Charter.
|